File size: 55,423 Bytes
6a78d3d 11ea0f0 6a78d3d 11ea0f0 2a0756c 6a78d3d 11ea0f0 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 2a0756c 6a78d3d 11ea0f0 6a78d3d 11ea0f0 6a78d3d 11ea0f0 6a78d3d 11ea0f0 | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 | """Populated extractions for each record type's extracted dictionary (#237, Phase B).
A record type's *extracted dictionary* is the set of fields that source supplies. This module holds a
committed, de-identified sample of that dictionary per record type, each value carrying the evidence that
supports it (invariant 2: no value without its evidence). The samples were assembled in-conversation, not
through the extraction API, so the seed is reproducible from the committed data alone:
- `pathology_extraction`: twenty-five fields read from twenty TCGA-UCEC pathology reports (eight checklist
fields plus seventeen further report fields: IHC, tumour size, adnexal/ovarian, lymph-node detail); evidence
is the verbatim report snippet.
- `clinical_join`: outcome, follow-up, and treatment fields derived from the real GDC longitudinal join;
evidence names the GDC record.
- `registry_join` / `local_research`: small illustrative samples, since those external sources are not part
of the open TCGA-UCEC corpus; evidence says so.
`coverage.seed_extractions` loads every record type into the `record_type_extractions` table. The raw
quantity is stored (invariant 1), and a field the source does not supply carries a coded absence
(`not_stated`) with null evidence.
"""
from __future__ import annotations
from endopath import coverage_data
PROJECT_ID = coverage_data.PROJECT_ID
# record_type_id -> {case_barcode -> {field -> (value, evidence)}}; evidence is None for a coded absence.
RECORD_TYPE_EXTRACTIONS: dict[str, dict[str, dict[str, tuple[str, str | None]]]] = {
'pathology_extraction': {
'TCGA-D1-A15W': {
'histologic_type': ('endometrioid', 'endometrial adenocarcinoma, endometrioid type'),
'histologic_grade': ('1', 'FIGO grade I (of III)'),
'myometrial_invasion_percent': ('0.7 cm of 1.8 cm', 'invading 0.7 cm into the 1.8 cm myometrial thickness'),
'cervical_stromal_invasion': ('absent', 'The cervix is uninvolved'),
'lymphovascular_space_invasion': ('not_stated', None),
'regional_lymph_node_status': ('positive', 'is positive for metastatic adenocarcinoma'),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('8.5', 'forming a mass (8.5 x 2.6 x 1.1 cm) invading 0.7 cm into the 1.8 cm myometrial thickness'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'Ovary, left, oophorectomy: Without diagnostic abnormality.'),
'seoc': ('No', 'Ovary, right, oophorectomy: Focus of endometriosis.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Full-pelvic node sampling performed | Full para-aortic', 'right and left pelvic lymph nodes and left para-aortic nodes'),
'check_lymphnodes_w_metas': ('not_stated', None),
'lymph_node_itc': ('not_stated', None),
'lymph_node_micrometastases': ('not_stated', None),
'lymph_node_macrometastases': ('not_stated', None),
},
'TCGA-AP-A1E0': {
'histologic_type': ('endometrioid', 'Adenocarcinoma, endometrioid type'),
'histologic_grade': ('2', 'FIGO Grade (For Endometrioid Types only): Grade 2'),
'myometrial_invasion_percent': ('9 mm of 26 mm', 'Measures 9mm in maximum depth. Myometrium thickness measures 26mm in the area of maximal tumor invasion.'),
'cervical_stromal_invasion': ('absent', 'Endocervical Invasion: Not identified.'),
'lymphovascular_space_invasion': ('constrained', 'Lymphovascular invasion: Identified.'),
'regional_lymph_node_status': ('positive', 'Metastatic adenocarcinoma in one of four lymph nodes (1/4)'),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('not_stated', None),
'omentum': ('not_stated', None),
'adnexal': ('No', 'Benign ovaries and fallopian tubes'),
'seoc': ('No', 'Benign ovaries and fallopian tubes'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Sentinel nodes performed (pelvic +/- para-aortic) | Full para-aortic', 'SP: Right external iliac sentinel lymph node ... SP: Right para-sortic lymph nodes; dissection'),
'check_lymphnodes_w_metas': ('not_stated', None),
'lymph_node_itc': ('not_stated', None),
'lymph_node_micrometastases': ('not_stated', None),
'lymph_node_macrometastases': ('not_stated', None),
},
'TCGA-AP-A0LV': {
'histologic_type': ('endometrioid', 'Tumor Type: Adenocarcinoma, endometrioid type.'),
'histologic_grade': ('1', 'FIGO Grade (For Endometrioid Types only): Grade 1.'),
'myometrial_invasion_percent': ('10 mm of 28 mm', 'Myometrial Invasion: (=<50%). Measures 10mm in maximum depth. Myometrium thickness measures 28mm in the area of maximal tumor.'),
'cervical_stromal_invasion': ('absent', 'Endocervical Invasion: Not identified.'),
'lymphovascular_space_invasion': ('not_identified', 'Lymphovascular invasion: Not identified.'),
'regional_lymph_node_status': ('negative', 'One benign lymph node (0/1).'),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('not_stated', None),
'omentum': ('not_stated', None),
'adnexal': ('No', 'Ovary with numerous cystic follicles and stromal hyperplasia. Benign fallopian tube with paratubal cysts.'),
'seoc': ('No', 'Ovary with numerous cystic follicles and stromal hyperplasia.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Debulking (selected enlarged nodes)', '4: SP: Enlarged left external iliac lymph node'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-AP-A059': {
'histologic_type': ('endometrioid', 'ADENOCARCINOMA OF ENDOMETRIUM, ENDOMETRIOID TYPE'),
'histologic_grade': ('3', 'FIGO GRADE III'),
'myometrial_invasion_percent': ('3 mm of 25 mm', 'THE MAXIMAL THICKNESS OF MYOMETRIAL INVASION IS 3 MM. THE THICKNESS OF THE MYOMETRIUM IN THE AREA OF MAXIMAL TUMOR INVASION IS 25 MM.'),
'cervical_stromal_invasion': ('absent', 'NO ENDOCERVICAL INVASION IS IDENTIFIED'),
'lymphovascular_space_invasion': ('not_identified', 'NO DEFINITE VASCULAR INVASION IS IDENTIFIED'),
'regional_lymph_node_status': ('negative', 'ONE BENIGN LYMPH NODE (0/1)'),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('mmr_deficient', 'IMMUNOHISTOCHEMICAL STAINS SHOW APPARENT LOSS OF MSH6 PROTEIN'),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('not_stated', None),
'omentum': ('not_stated', None),
'adnexal': ('No', 'ALL ADNEXA ARE UNREMARKABLE.'),
'seoc': ('No', 'ALL ADNEXA ARE UNREMARKABLE.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Full-pelvic node sampling performed | Full para-aortic', '2: SP: Left external iliac lymph node 3: SP: Left hypogastric lymph node 4: SP: Left obturator lymph node 5: SP: Right external iliac lymph node 6: SP: Right obturator lymph node 7: SP: Left para-aortic lymph node 8: SP: Right para-aortic lymph nodes'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-BG-A0LX': {
'histologic_type': ('endometrioid', 'MODERATELY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA OF THE ENDOMETRIUM'),
'histologic_grade': ('2', 'Moderately differentiated (FIGO 2)'),
'myometrial_invasion_percent': ('up to 90% of the myometrial uterine wall', 'ENDOMETRIOID CARCINOMA PENETRATES UP TO 90% OF THE MYOMETRIAL UTERINE WALL'),
'cervical_stromal_invasion': ('absent', 'UTERINE CERVIX -CHRONIC CYSTIC CERVICITIS AND SQUAMOUS METAPLASIA FREE OF TUMOR'),
'lymphovascular_space_invasion': ('constrained', 'ANGIOLYMPHATIC INVASION IDENTIFIED'),
'regional_lymph_node_status': ('negative', 'N STAGE, PATHOLOGIC: pNO'),
'pathologic_stage': ('IB', 'FIGO STAGE: IB'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('7.5', 'TUMOR SIZE: Maximum dimension: 7.5 mm'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'LEFT OVARY WITH FOCI OF HEMOSIDERIN LADEN MACROPHAGES, ENDOMETRIOSIS, PHYSIOLOGIC CHANGES AND FOCAL MICROCALCIFICATIONS. ... RIGHT OVARY WITH EPITHELIAL INCLUSION, MICROCALCIFICATIONS AND PHYSIOLOGICAL CHANGES.'),
'seoc': ('No', 'RIGHT OVARY WITH EPITHELIAL INCLUSION, MICROCALCIFICATIONS AND PHYSIOLOGICAL CHANGES.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Full-pelvic node sampling performed | Full para-aortic', 'PART 2: LEFT PELVIC LYMPH NODES - SEVEN (7) LEFT PELVIC LYMPH NODES, FREE OF TUMOR (0/7). ... PART 5: RIGHT PERIAORTIC LYMPH NODES - THREE (3) RIGHT PERIAORTIC LYMPH NODES, FREE OF TUMOR (0/3).'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-BG-A0M0': {
'histologic_type': ('endometrioid', 'ENDOMETRIAL ADENOCARCINOMA, ENDOMETRIOID TYPE'),
'histologic_grade': ('1', 'Well differentiated (FIGO 1)'),
'myometrial_invasion_percent': ('0.1 cm of 1.5 cm myometrium (6%)', 'TUMOR INVADES 0.1 CM OF 1.5 CM MYOMETRIUM (6%)'),
'cervical_stromal_invasion': ('absent', 'CERVIX FREE OF TUMOR.'),
'lymphovascular_space_invasion': ('not_identified', 'LYMPHOVASCULAR INVASION IS NOT IDENTIFIED.'),
'regional_lymph_node_status': ('negative', 'ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1)'),
'pathologic_stage': ('IA', 'FIGO - IA (current classification)'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('5.2', 'INVASIVE WELL DIFFERENTIATED ENDOMETRIAL ADENOCARCINOMA, ENDOMETRIOID TYPE, FIGO GRADE 1, NUCLEAR GRADE 1, 5.2 CM (GROSS)'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'BILATERAL ADNEXA, FREE OF TUMOR.'),
'seoc': ('No', 'BILATERAL OVARIES WITH SURFACE EPITHELIAL INCLUSIONS.'),
'perit_wash': ('Negative', 'PELVIC WASH – NEGATIVE.'),
'lymph_node_sampling': ('Full-pelvic node sampling performed', 'PART 2: LYMPH NODES, RIGHT EXTERNAL ILIAC, DISSECTIONS – ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 3: LYMPH NODES, LEFT EXTERNAL ILIAC, DISSECTION– BENIGN FIBROFATTY TISSUE, NO LYMPH NODE IDENTIFIED.'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-BG-A0MH': {
'histologic_type': ('endometrioid', 'MODERATELY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA (GRADE 2)'),
'histologic_grade': ('2', 'Moderately differentiated (FIGO 2)'),
'myometrial_invasion_percent': ('up to 80% of myometrial thickness', 'PENETRATING UP TO 80% OF MYOMETRIAL THICKNESS'),
'cervical_stromal_invasion': ('absent', 'T STAGE, PATHOLOGIC: pT1c'),
'lymphovascular_space_invasion': ('not_stated', None),
'regional_lymph_node_status': ('negative', 'Number of lymph nodes positive:: 0'),
'pathologic_stage': ('IC', 'FIGO STAGE: IC'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('4.5', 'TUMOR SIZE: Maximum dimension: 4.5 cm'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'OVARY WITH MATURE CYSTIC TERATOMA, NO ADENOCARCINOMA IS SEEN ... LEFT OVARY WITH MICROSCOPIC MATURE CYSTIC TERATOMA AND SEROSAL ADHESIONS, NO ADENOCARCINOMA IS SEEN'),
'seoc': ('Yes', 'OVARY WITH MATURE CYSTIC TERATOMA, NO ADENOCARCINOMA IS SEEN'),
'perit_wash': ('Negative', 'The peritoneal cytology is negative.'),
'lymph_node_sampling': ('Full-pelvic node sampling performed; Full para-aortic', 'PART 3: LYMPH NODES, LEFT PELVIC, BIOPSY; PART 4: LYMPH NODES, LEFT PERIAORTIC, BIOPSY; PART 5: LYMPH NODES, RIGHT PELVIC, BIOPSY; PART 6: LYMPH NODES, RIGHT PERIAORTIC, BIOPSY'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-BG-A0MO': {
'histologic_type': ('endometrioid', 'ENDOMETRIOID ADENOCARCINOMA OF THE ENDOMETRIUM'),
'histologic_grade': ('1', 'FIGO GRADE 1'),
'myometrial_invasion_percent': ('0.5 cm of 1.4 cm', '0.5 CM INVASION INTO 1.4 CM. TOTAL MYOMETRIAL WALL THICKNESS'),
'cervical_stromal_invasion': ('absent', 'CERVIX, NEGATIVE FOR NEOPLASM'),
'lymphovascular_space_invasion': ('not_identified', 'NO LYMPHOVASCULAR INVASION IS IDENTIFIED'),
'regional_lymph_node_status': ('negative', 'Number of lymph nodes positive:: 0'),
'pathologic_stage': ('IB', 'FIGO STAGE: IB'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('2.5', 'TUMOR SIZE: Maximum dimension: 2.5 cm'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'RIGHT AND LEFT OVARIES WITH ENDOSALPINGIOSIS AND BENIGN SURFACE FIBROMAS, NEGATIVE FOR NEOPLASM.'),
'seoc': ('No', 'RIGHT AND LEFT OVARIES WITH ENDOSALPINGIOSIS AND BENIGN SURFACE FIBROMAS, NEGATIVE FOR NEOPLASM.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Full-pelvic node sampling performed, Full para-aortic', 'PART 2: RIGHT PELVIC LYMPH NODES, BIOPSY... PART 4: RIGHT OBTURATOR LYMPH NODES, BIOPSY... PART 5: RIGHT COMMON AND PERIAORTIC LYMPH NODES, BIOPSY... PART 7: LEFT PELVIC BICIRCUMFLEX LYMPH NODES, BIOPSY... PART 9: LEFT OBTURATOR LYMPH NODES, BIOPSY'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-BG-A0VV': {
'histologic_type': ('endometrioid', 'Endometroid adenocarcinoma, NOS'),
'histologic_grade': ('1', 'Well differentiated (FIGO 1)'),
'myometrial_invasion_percent': ('Less than 1/2 thickness of myometrium', 'Less than 1/2 thickness of myometrium'),
'cervical_stromal_invasion': ('not_stated', None),
'lymphovascular_space_invasion': ('not_stated', None),
'regional_lymph_node_status': ('negative', 'Number of lymph nodes positive:: 0. LYMPH NODES EXAMINED: Total number of lymph nodes examined: 9'),
'pathologic_stage': ('IA', 'FIGO STAGE: IA'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('2.5', 'Maximum dimension: 25 mm'),
'omentum': ('not_stated', None),
'adnexal': ('not_stated', None),
'seoc': ('not_stated', None),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Full-pelvic node sampling performed | Full para-aortic', 'pelvic and periaortic lymph node dissection'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-BG-A3PP': {
'histologic_type': ('serous', 'TUMOR TYPE: Serous adenocarcinoma'),
'histologic_grade': ('3', 'Poorly differentiated (FIGO) 3)'),
'myometrial_invasion_percent': ('approximately 85%', 'INVADING APPROXIMAYELY 85% OF MYOMETRIUM'),
'cervical_stromal_invasion': ('present', 'ADENOCARCINOMA INVADES ENDOCERVICAL GLANDS AND CERVICAL STROMA'),
'lymphovascular_space_invasion': ('constrained', 'MULTIFOCAL LYMPHOVASCULAR INVASION IDENTIFIED'),
'regional_lymph_node_status': ('negative', 'N STAGE, PATHOLOGIC: pNO'),
'pathologic_stage': ('II', 'FIGO STAGE: II'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('4.3', 'TUMOR SIZE: Maximum dimension: 43 mm'),
'omentum': ('No', 'PART 6: OMENTUM, OMENTECTOMY - A. NEGATIVE FOR TUMOR.'),
'adnexal': ('No', 'BILATERAL OVARIES NEGATIVE FOR TUMOR, WITH PHYSIOLOGIC CHANGES AND EPITHELIAL INCLUSIONS.'),
'seoc': ('No', 'BILATERAL OVARIES NEGATIVE FOR TUMOR, WITH PHYSIOLOGIC CHANGES AND EPITHELIAL INCLUSIONS.'),
'perit_wash': ('Positive', 'Pelvic cytology ... is suspicious for malignant cells.'),
'lymph_node_sampling': ('Full-pelvic node sampling performed | Full para-aortic', 'PART 2: LYMPH NODES, LEFT PELVIC, DISSECTION; PART 3: LYMPH NODES, LEFT PERIAORTIC, DISSECTION; PART 4: LYMPH NODES, RIGHT PELVIC, DISSECTION; PART 5: LYMPH NODES, RIGHT PERIAORTIC, DISSECTION'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-D1-A16O': {
'histologic_type': ('endometrioid', 'endometrioid type'),
'histologic_grade': ('1', 'FIGO grade I (of III)'),
'myometrial_invasion_percent': ('0.1 to 0.2 cm of 1.6 cm', 'The tumor invades superficially (0.1 to 0.2 cm) into the myometrium (total wall thickness, 1.6 cm)'),
'cervical_stromal_invasion': ('absent', 'The tumor does not involve the endocervix.'),
'lymphovascular_space_invasion': ('constrained', 'Lymphovascular space invasion is identified.'),
'regional_lymph_node_status': ('not_stated', None),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': (5.0, 'polypoid mass (5.0 x 3.8 x 1.5 cm) circumferentially involving the endometrium'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'The ovaries show bilateral corpus luteal cysts (right--1.7 cm in greatest dimension; left--1.3 cm in greatest dimension). The bilateral fallopian tubes are not identified.'),
'seoc': ('No', 'The ovaries show bilateral corpus luteal cysts (right--1.7 cm in greatest dimension; left--1.3 cm in greatest dimension)'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('not_stated', None),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-SL-A6JA': {
'histologic_type': ('endometrioid', 'Histologic Type: Endometrioid andenocarcinoma'),
'histologic_grade': ('3', 'FIGO grade 3 (architectural grade 2, cytologic grade 3)'),
'myometrial_invasion_percent': ('1.1 cm of 1.8 cm', 'Maximal depth of invasion is 1.1cm in total thickness of 1.8cm'),
'cervical_stromal_invasion': ('present', 'Endocervical stromal invasion is seen'),
'lymphovascular_space_invasion': ('constrained', 'Lymphatic invasion is seen with a D240'),
'regional_lymph_node_status': ('negative', 'pNO'),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('not_stated', None),
'omentum': ('not_stated', None),
'adnexal': ('No', 'The bilateral ovaries and fallopian tubes are uninvolved by tumor and demonstrate atrophic features.'),
'seoc': ('No', 'The bilateral ovaries and fallopian tubes are uninvolved by tumor and demonstrate atrophic features.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('not_stated', None),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-AJ-A5DV': {
'histologic_type': ('endometrioid', 'Endometrioid adenocarcinoma'),
'histologic_grade': ('2', 'Histologic grade 2/3'),
'myometrial_invasion_percent': ('0.5 cm depth of invasion of 1.5 cm total myometrial thickness', 'Depth of invasion: 0.5 cm (total myometrial thickness 1.5 cm; tumor. predominantly exophytic; 0.5 cm)'),
'cervical_stromal_invasion': ('absent', 'Upper portion of endocervical glands involved with no. stromal invasion identified'),
'lymphovascular_space_invasion': ('not_identified', 'Lymphovascular invasion: Not identified'),
'regional_lymph_node_status': ('negative', 'Right pelvic lymph node: One (1) negative lymph node'),
'pathologic_stage': ('pT1a,pN0', 'AJCC pathologic stage: pT1a,pNo.'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': (4.8, 'Maximum tumor size: 4.8 cm.'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'Left and right adnexa with physiologic changes.'),
'seoc': ('No', 'Left and right adnexa with physiologic changes.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('not_stated', None),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-AX-A3FS': {
'histologic_type': ('endometrioid', 'HIGH GRADE ENDOMETRIOID ADENOCARCINOMA'),
'histologic_grade': ('3', 'HISTOLOGIC GRADE: FIGO grade 3'),
'myometrial_invasion_percent': ('5 mm depth of invasion, 25 mm myometrial thickness', 'Depth of invasion: 5 mm. Myometrial thickness: 25 mm.'),
'cervical_stromal_invasion': ('absent', 'INVOLVEMENT OF CERVIX: Not involved.'),
'lymphovascular_space_invasion': ('focal', 'FOCAL VASCULAR SPACE INVASION'),
'regional_lymph_node_status': ('negative', 'pNO: No regional lymph node metastasis.'),
'pathologic_stage': ('IA', 'pTla(IA]'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('4', 'TUMOR SIZE: Greatest dimension: 4'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'BILATERAL OVARIES AND FALLOPIAN TUBES PHYSIOLOGICAL CHANGES NO TUMOR IDENTIFIED'),
'seoc': ('No', 'BILATERAL OVARIES AND FALLOPIAN TUBES PHYSIOLOGICAL CHANGES NO TUMOR IDENTIFIED'),
'perit_wash': ('Negative', '*PERITONEAL ASCITIC FLUID: *Negative for malignancy/normal/benign'),
'lymph_node_sampling': ('Full-pelvic node sampling performed', 'LYMPH NODE SAMPLING: Performed Pelvic lymph nodes'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-BG-A222': {
'histologic_type': ('endometrioid', 'TUMOR TYPE: Endometroid adenocarcinoma, NOS.'),
'histologic_grade': ('3', 'Poorly differentiated (FIGO 3).'),
'myometrial_invasion_percent': ('approximately 35%', 'INVADING APPROXIMATELY 35%. OF MYOMETRIUM'),
'cervical_stromal_invasion': ('absent', 'CHRONIC CERVICITIS, SQUAMOUS METAPLASIA, REACTIVE CHANGES AND MICROGLANDULAR'),
'lymphovascular_space_invasion': ('focal', 'FOCAL LYMPHOVASCULAR INVASION IDENTIFIED.'),
'regional_lymph_node_status': ('negative', 'Number of lymph nodes positive:: 0.'),
'pathologic_stage': ('IA', 'FIGO STAGE: IA.'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('7.0', 'TUMOR SIZE: Maximum dimension: 70 mm'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'BILATERAL OVARIES AND FALLOPIAN TUBES, NEGATIVE FOR TUMOR.'),
'seoc': ('No', 'BILATERAL OVARIES AND FALLOPIAN TUBES, NEGATIVE FOR TUMOR.'),
'perit_wash': ('Negative', 'Pelvic cytology (...) is negative for malignant cells.'),
'lymph_node_sampling': ('Full-pelvic node sampling performed | Full para-aortic', 'PROCEDURE: ... pelvic and periaortic lymph node dissection.'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-D1-A0ZQ': {
'histologic_type': ('endometrioid', 'endometrial adenocarcinoma, endometrioid. type with. mucinous differentiation'),
'histologic_grade': ('2', 'FIGO. grade 2 (of 3) endometrial adenocarcinoma'),
'myometrial_invasion_percent': ('1.2 cm of 2.0 cm total wall thickness', 'The tumor invades 1.2 cm into the myometrium (total wall. thickness, 2.0. cm)'),
'cervical_stromal_invasion': ('absent', 'The tumor does not involve the endocervix.'),
'lymphovascular_space_invasion': ('not_identified', 'Lymphovascular. space invasion is not identified.'),
'regional_lymph_node_status': ('not_examined', '[AJCCpT1cNxMx]'),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('2.7', 'mass (2.7 x 2.6 x 0.7 cm)'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'The right ovary shows a peritoneal inclusion cyst. The left ovary shows a serous cystadenoma. Both fallopian tubes are unremarkable.'),
'seoc': ('Yes', 'The left ovary shows a serous cystadenoma.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('not_applicable', None),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-D1-A16F': {
'histologic_type': ('endometrioid', 'Endometrial adenocarcinoma,. endometrioid. type'),
'histologic_grade': ('2', 'FIGO grade II (of III)'),
'myometrial_invasion_percent': ('0.5 cm (2.0 cm total myometrial thickness)', 'invades the myometrium to a. maximal depth. of 0.5 cm (2.0 cm total myometrial thickness)'),
'cervical_stromal_invasion': ('absent', 'The cervix is uninvolved.'),
'lymphovascular_space_invasion': ('not_stated', None),
'regional_lymph_node_status': ('negative', 'right. pelvic lymph nodes are negative for tumor'),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('7.5', 'forming a polypoid mass (7.5 x 2.5 x 1.3 cm)'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'Ovary and fallopian tube, right salpingo-oophorectomy: No diagnostic abnormalities.'),
'seoc': ('No', 'Ovary and fallopian tube, right salpingo-oophorectomy: No diagnostic abnormalities.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Full-pelvic node sampling performed | Full para-aortic', 'right and left pelvic lymph nodes (laparoscopically), right and left para-aortic lymph nodes above and below the inferior mesenteric artery (laparoscopically)'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-D1-A2G5': {
'histologic_type': ('endometrioid', 'endometrial. adenocarcinoma, endometrioid type'),
'histologic_grade': ('3', 'FIGO grade III (of III)'),
'myometrial_invasion_percent': ('0.4 cm of 2.0 cm total myometrial thickness', '0.4 cm into the myometrium (total myometrial thickness,. 2.0 cm)'),
'cervical_stromal_invasion': ('absent', 'The cervix is uninvolved by tumor'),
'lymphovascular_space_invasion': ('not_identified', 'Angiolymphatic invasion is not identified'),
'regional_lymph_node_status': ('positive', 'is positive for a microscopic. focus of. metastatic adenocarcinoma'),
'pathologic_stage': ('not_stated', None),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('8.4', 'forming an 8.4 x 3.5 x 2.4 cm polypoid mass filling the endometrial cavity'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'Ovary and fallopian tube, right and left, salpingo-oophorectomy: Without diagnostic abnormality.'),
'seoc': ('No', 'Ovary and fallopian tube, right and left, salpingo-oophorectomy: Without diagnostic abnormality.'),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Full-pelvic node sampling performed | Full para-aortic', 'Lymph nodes, left pelvic, excision: Multiple left pelvic lymph nodes (4 external iliac, 2 internal iliac, 5 common iliac, 7 obturator) are negative for tumor. Lymph nodes, right and left para-aortic, lymphadenectomy: Multiple para-aortic lymph nodes above the inferior mesenteric artery (5 right, 5 left) are negative for tumor.'),
'check_lymphnodes_w_metas': ('not_stated', None),
'lymph_node_itc': ('not_stated', None),
'lymph_node_micrometastases': ('not_stated', None),
'lymph_node_macrometastases': ('not_stated', None),
},
'TCGA-EY-A1GI': {
'histologic_type': ('endometrioid', 'Moderately differentiated endometrioid adenocarcinoma'),
'histologic_grade': ('2', 'overall FIGO grade 2'),
'myometrial_invasion_percent': ('1.3 cm of 1.7 cm (76%)', 'Tumor invades into the outer half of the myometrial wall to 1.3 cm out of 1.7 cm in total myometrial wall thickness. (76%)'),
'cervical_stromal_invasion': ('absent', 'Cervix. - No tumor seen.'),
'lymphovascular_space_invasion': ('focal', 'Focal lymphovascular space invasion present'),
'regional_lymph_node_status': ('negative', 'Sixteen lymph nodes, no tumor seen (0/16)'),
'pathologic_stage': ('IB', 'FIGO stage grouping: IB.'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('6.0', 'Tumor is roughly circumferential and measures approximately 6 cm from cervical to fundic and approximately 3.3 cm in width'),
'omentum': ('Unknown (not sampled)', 'Received are three appropriately labeled containers.'),
'adnexal': ('not_stated', None),
'seoc': ('not_stated', None),
'perit_wash': ('not_stated', None),
'lymph_node_sampling': ('Full-pelvic node sampling performed', 'undergoing a radical hysterectomy, bilateral salpingo-oophorectomy and bilateral pelvic lymphadenectomy.'),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
'TCGA-KP-A3W1': {
'histologic_type': ('serous', 'High-grade endometrial serous carcinoma'),
'histologic_grade': ('3', 'Figo grade 3/3'),
'myometrial_invasion_percent': ('inner half of myometrium (superficial); invasion depth 0.5 cm, least thickness of uninvolved myometrium 1.3 cm', 'Only superficial invasion of inner half of myometrium'),
'cervical_stromal_invasion': ('absent', 'does not involve the endocervix'),
'lymphovascular_space_invasion': ('not_identified', 'No lymphovascular invasion'),
'regional_lymph_node_status': ('negative', 'Three benign lymph nodes, negative. for metastasis'),
'pathologic_stage': ('pT1aN0', 'pTlaNO'),
'molecular_classification': ('not_stated', None),
'date_biopsy_reported': ('not_stated', None),
'msh6_staining_biopsy': ('not_stated', None),
'pms2_staining_biopsy': ('not_stated', None),
'msh2_staining_biopsy': ('not_stated', None),
'mlh1_staining_biopsy': ('not_stated', None),
'p53_staining_biopsy': ('not_stated', None),
'mlh1meth_testing_ans': ('not_stated', None),
'tumor_size': ('4.5', 'the endometrium is involved by tumor, 4.5 cm in greatest dimension'),
'omentum': ('not_stated', None),
'adnexal': ('No', 'Histologically unremarkable ovaries and fallopian tubes.'),
'seoc': ('No', 'Histologically unremarkable ovaries and fallopian tubes.'),
'perit_wash': ('Negative', 'Pelvic washings: Benign mesothelial cells and chronic inflammatory cells.'),
'lymph_node_sampling': ('not_stated', None),
'check_lymphnodes_w_metas': ('not_applicable', None),
'lymph_node_itc': ('not_applicable', None),
'lymph_node_micrometastases': ('not_applicable', None),
'lymph_node_macrometastases': ('not_applicable', None),
},
},
'clinical_join': {
'TCGA-D1-A15W': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('915', 'GDC last-follow-up record: days_to_last_follow_up = 915'),
'chemotherapy': ('administered', 'GDC treatment record: chemotherapy'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation, implants'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-AP-A1E0': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('1832', 'GDC last-follow-up record: days_to_last_follow_up = 1832'),
'chemotherapy': ('administered', 'GDC treatment record: chemotherapy'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-AP-A0LV': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('763', 'GDC last-follow-up record: days_to_last_follow_up = 763'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-AP-A059': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('1461', 'GDC last-follow-up record: days_to_last_follow_up = 1461'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation, implants'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-BG-A0LX': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('614', 'GDC last-follow-up record: days_to_last_follow_up = 614'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation, implants'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-BG-A0M0': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('588', 'GDC last-follow-up record: days_to_last_follow_up = 588'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-BG-A0MH': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('1930', 'GDC last-follow-up record: days_to_last_follow_up = 1930'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation, external beam'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-BG-A0MO': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('1309', 'GDC last-follow-up record: days_to_last_follow_up = 1309'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation, implants'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-BG-A0VV': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('1553', 'GDC last-follow-up record: days_to_last_follow_up = 1553'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-BG-A3PP': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('WT-With Tumor', 'GDC follow-up record: disease_response = WT-With Tumor'),
'days_to_last_follow_up': ('681', 'GDC last-follow-up record: days_to_last_follow_up = 681'),
'chemotherapy': ('administered', 'GDC treatment record: chemotherapy'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation, external beam'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-D1-A16O': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('1023', 'GDC last-follow-up record: days_to_last_follow_up = 1023'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-SL-A6JA': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('7', 'GDC last-follow-up record: days_to_last_follow_up = 7'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-AJ-A5DV': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('679', 'GDC last-follow-up record: days_to_last_follow_up = 679'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-AX-A3FS': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('not_stated', None),
'days_to_last_follow_up': ('7', 'GDC last-follow-up record: days_to_last_follow_up = 7'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-BG-A222': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('291', 'GDC last-follow-up record: days_to_last_follow_up = 291'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-D1-A0ZQ': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('0', 'GDC last-follow-up record: days_to_last_follow_up = 0'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-D1-A16F': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('80', 'GDC last-follow-up record: days_to_last_follow_up = 80'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-D1-A2G5': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('Unknown', 'GDC follow-up record: disease_response = Unknown'),
'days_to_last_follow_up': ('1455', 'GDC last-follow-up record: days_to_last_follow_up = 1455'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-EY-A1GI': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('710', 'GDC last-follow-up record: days_to_last_follow_up = 710'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: brachytherapy, high dose'),
'hormone_therapy': ('not_stated', None),
},
'TCGA-KP-A3W1': {
'vital_status': ('Alive', 'GDC demographic record: vital_status = Alive'),
'disease_response': ('TF-Tumor Free', 'GDC follow-up record: disease_response = TF-Tumor Free'),
'days_to_last_follow_up': ('288', 'GDC last-follow-up record: days_to_last_follow_up = 288'),
'chemotherapy': ('administered', 'GDC treatment record: pharmaceutical therapy, nos'),
'radiation_therapy': ('administered', 'GDC treatment record: radiation therapy, nos'),
'hormone_therapy': ('not_stated', None),
},
},
'registry_join': {
'TCGA-D1-A15W': {
'cause_of_death': ('not_applicable', None),
'second_primary_cancer': ('none reported', 'Illustrative example; this source is not part of the open TCGA-UCEC corpus.'),
},
'TCGA-BG-A3PP': {
'cause_of_death': ('not_stated', None),
'second_primary_cancer': ('none reported', 'Illustrative example; this source is not part of the open TCGA-UCEC corpus.'),
},
},
'local_research': {
'TCGA-AP-A059': {
'tumor_board_reviewed': ('yes', 'Illustrative example; this source is not part of the open TCGA-UCEC corpus.'),
'trial_enrollment': ('not enrolled', 'Illustrative example; this source is not part of the open TCGA-UCEC corpus.'),
},
'TCGA-SL-A6JA': {
'tumor_board_reviewed': ('yes', 'Illustrative example; this source is not part of the open TCGA-UCEC corpus.'),
'trial_enrollment': ('not enrolled', 'Illustrative example; this source is not part of the open TCGA-UCEC corpus.'),
},
},
}
|